Liu Xingui

Xingui Liu, Ph.D., is an Assistant Professor in the Department of Medicinal Chemistry at the College of Pharmacy, University of Florida. Her research focuses on proximity agent-based early drug discovery, including hit identification, lead optimization, and assay development. Before beginning her independent research career, Dr. Liu was a Marie Skłodowska-Curie Fellow at the Center for Targeted Protein Degradation (CeTPD) at the University of Dundee, where she developed PROTAC degraders targeting Leucine-Rich Repeat Kinase 2 (LRRK2), a promising therapeutic target for Parkinson’s disease. Prior to that, she was a Postdoctoral Associate at the University of Florida. Dr. Liu earned her Ph.D. from the University of Arkansas for Medical Sciences.